{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:03:31Z","timestamp":1768878211856,"version":"3.49.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamaoncol.2018.3732","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T22:31:30Z","timestamp":1539988290000},"page":"91","source":"Crossref","is-referenced-by-count":24,"title":["Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes"],"prefix":"10.1001","volume":"5","author":[{"given":"Amar U.","family":"Kishan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"},{"name":"Department of Urology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Seiferheld","sequence":"additional","affiliation":[{"name":"NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Collette","sequence":"additional","affiliation":[{"name":"European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiri A.","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard M.","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cedars Sinai, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bolla","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Maingon","sequence":"additional","affiliation":[{"name":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, Sorbonne Universit\u00e9 Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"De Reijke","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centers, Academic Medical Center, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald E.","family":"Hanks","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Nickols","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"},{"name":"Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rettig","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles"},{"name":"Division of Hematology and Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Drakaki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Reiter","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick A.","family":"Kupelian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"cbr180014r1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semradonc.2016.08.009","article-title":"Optimization of the radiation management of high-risk prostate cancer.","volume":"27","author":"Nguyen","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"cbr180014r2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them.","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"cbr180014r3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.eururo.2015.08.057","article-title":"Is Gleason grade 5 prostate cancer resistant to conventional androgen deprivation therapy?","volume":"69","author":"D\u2019Amico","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"cbr180014r4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2014long-term results of phase III RTOG 85-31.","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"cbr180014r5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"cbr180014r6","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.","volume":"26","author":"Horwitz","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"cbr180014r7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"issue":"24","key":"cbr180014r8","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer.","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"cbr180014r9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.2015.64.8055","article-title":"Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: results of EORTC trial 22991.","volume":"34","author":"Bolla","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"cbr180014r10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory.","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"issue":"11","key":"cbr180014r12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/2159-8290.CD-13-0172","article-title":"Androgen receptor signaling regulates DNA repair in prostate cancers.","volume":"3","author":"Polkinghorn","year":"2013","journal-title":"Cancer Discov"},{"issue":"22","key":"cbr180014r13","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1158\/0008-5472.CAN-15-0892","article-title":"Androgen receptor upregulation mediates radioresistance after ionizing radiation.","volume":"75","author":"Spratt","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"cbr180014r14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer.","volume":"319","author":"Kishan","year":"2018","journal-title":"JAMA"},{"issue":"33","key":"cbr180014r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5330","article-title":"Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.","volume":"5","author":"Brookes","year":"2001","journal-title":"Health Technol Assess"},{"key":"cbr180014r11","unstructured":"TeamRDCR. a language and environment for statistical computing. 2016; https:\/\/www.gbif.org\/tool\/81287\/r-a-language-and-environment-for-statistical-computing. Accessed November 15, 2017."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2703116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:10:08Z","timestamp":1547136608000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.3732"}},"subtitle":["A Systematic Review and Patient-Level Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.3732","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}